Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SVA - Week In Review: Suzhou's Adagene To Stage $125 Million IPO On NASDAQ

SVA - Week In Review: Suzhou's Adagene To Stage $125 Million IPO On NASDAQ

Sinovac Biotech Ltd.
  • Adagene, a Suzhou immunotherapy company, plans to raise up to $125 million in a US IPO on the NASDAQ Exchange.
  • TenNor Therapeutics (Suzhou), a company that develops dual-action antibiotics, announced a research collaboration with Janssen Pharma that will use TenNor's drug conjugation platform to discover new therapies for the treatment of nontuberculous mycobacteria diseases.
  • Sinovac Biotech of Beijing plans to start a second manufacturing line for CoronaVac, the company's inactivated COVID-19 vaccine, with the goal of producing two billion doses this year.

For further details see:

Week In Review: Suzhou's Adagene To Stage $125 Million IPO On NASDAQ
Stock Information
Company Name: Sinovac Biotech Ltd.
Stock Symbol: SVA
Market: NASDAQ
Website: sinovac.com
Menu
SVA SVA Quote SVA Short SVA News SVA Articles SVA Message Board
Get SVA Alerts

News, Short Squeeze, Breakout and More Instantly...